Sector Chart Celemics, Inc.

Stocks

A331920

KR7331920009

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 07/08/2026			5-day change	1st Jan Change
10,240.00 ^KRW	+6.89%		+13.15%	+277.16%

24/06	Celemics, Inc. announced that it expects to receive KRW 9.999995577 billion in funding from Cnp Co., Ltd.	CI
29/05	Celemics, Inc. announced that it has received KRW 11.5999945 billion in funding	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Other Biotechnology & Medical Research

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
CELEMICS, INC.	81.24M	-	-	-	-	-
LONZA GROUP AG	49.47B
REVOLUTION MEDICINES, INC.	43.61B	-	-	-	-	-
BEONE MEDICINES AG	39.6B
IQVIA HOLDINGS INC.	39.29B
CELLTRION, INC.	32.43B